HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linfu Zhou Selected Research

Linfu Zhou Research Topics

Disease

11Inflammation (Inflammations)
01/2024 - 01/2005
6Asthma (Bronchial Asthma)
12/2022 - 05/2009
6Chronic Obstructive Pulmonary Disease (COPD)
05/2022 - 03/2014
5Neoplasms (Cancer)
01/2021 - 04/2016
5Neoplasm Metastasis (Metastasis)
01/2019 - 04/2016
4Infections
08/2021 - 01/2005
4Hepatocellular Carcinoma (Hepatoma)
10/2019 - 04/2016
2Stroke (Strokes)
01/2023 - 12/2022
2Respiratory Hypersensitivity
12/2022 - 05/2012
2Experimental Nervous System Autoimmune Disease
01/2022 - 01/2017
2Colorectal Neoplasms (Colorectal Cancer)
04/2018 - 01/2018
1Myocardial Infarction
10/2023
1Airway Remodeling
12/2022
1Dyspnea (Shortness of Breath)
05/2022
1Virus Diseases (Viral Diseases)
03/2021
1Carcinoma (Carcinomatosis)
01/2021
1Hypertension (High Blood Pressure)
11/2020
1Pneumonia (Pneumonitis)
01/2019
1Pulmonary Edema
01/2019
1Carcinogenesis
04/2018
1Autoimmune Diseases (Autoimmune Disease)
01/2017
1Triple Negative Breast Neoplasms
01/2017
1Polymyositis
01/2017
1Disease Progression
04/2016
1Meningeal Tuberculosis (Tuberculous Meningitis)
02/2016
1Cryptococcal Meningitis
02/2016
1Encephalitis (Encephalitis, Rasmussen)
02/2016
1Fibrosis (Cirrhosis)
01/2016

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
10/2023 - 03/2014
5Proteins (Proteins, Gene)FDA Link
12/2022 - 05/2012
3OvalbuminIBA
12/2022 - 05/2012
3PhosphoproteinsIBA
10/2019 - 04/2016
3CytokinesIBA
01/2019 - 05/2009
2Therapeutic UsesIBA
12/2022 - 01/2016
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022 - 01/2017
2Anti-Bacterial Agents (Antibiotics)IBA
08/2021 - 01/2020
2Peptides (Polypeptides)IBA
03/2021 - 12/2012
2Immunoglobulins (Immunoglobulin)IBA
02/2021 - 05/2012
2RNA (Ribonucleic Acid)IBA
04/2018 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 05/2012
2Toll-Like Receptor 4IBA
01/2017 - 01/2016
2Neuroprotective AgentsIBA
12/2012 - 10/2012
1Interleukin-6 (Interleukin 6)IBA
01/2024
1Interleukin-8 (Interleukin 8)IBA
01/2024
1ResveratrolIBA
01/2024
1Hematoxylin (Haematoxylon)IBA
01/2024
1Eosine Yellowish-(YS) (Eosin)IBA
01/2024
1Troponin IIBA
10/2023
1Nucleotide AptamersIBA
10/2023
1wogoninIBA
12/2022
1HMGB1 Protein (HMG1)IBA
12/2022
1flavoneIBA
12/2022
1LipopolysaccharidesIBA
12/2022
1Cefaclor (Ceclor)FDA LinkGeneric
09/2022
1Levobunolol (AKBeta)FDA LinkGeneric
09/2022
1TrapidilIBA
09/2022
1Ajmaline (Wolfina)FDA Link
09/2022
1Indoprofen (Dexindoprofen)IBA
09/2022
1Aminoglutethimide (Cytadren)FDA Link
09/2022
1Bethanechol (Duvoid)FDA LinkGeneric
09/2022
1Dimenhydrinate (DMH)FDA LinkGeneric
09/2022
1Ethionamide (Trecator-SC)FDA Link
09/2022
1MimosineIBA
09/2022
1Iloprost (Ventavis)FDA Link
09/2022
1ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA
01/2022
1Sirolimus (Rapamycin)FDA Link
01/2022
1ORALIT (ORS)IBA
06/2021
1AntigensIBA
03/2021
1Sialic Acid Binding Immunoglobulin-like LectinsIBA
02/2021
1N-Acetylneuraminic Acid (Sialic Acid)IBA
02/2021
1LectinsIBA
02/2021
1apatinibIBA
11/2020
1Docetaxel (Taxotere)FDA Link
11/2020
1Levofloxacin (Levaquin)FDA Link
01/2020
1Clarithromycin (Biaxin)FDA LinkGeneric
01/2020
1MidkineIBA
04/2019
1Antisense OligonucleotidesIBA
04/2019
1Capsid Proteins (Capsid Protein)IBA
01/2019
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2019
1MicroRNAs (MicroRNA)IBA
04/2018
1Circular RNAIBA
01/2018
1InterferonsIBA
01/2017
1Epidermal Growth Factor (EGF)IBA
01/2017
1Interleukin-17 (Interleukin 17)IBA
01/2017
1Small Interfering RNA (siRNA)IBA
04/2016
1A-factor (Streptomyces)IBA
04/2016
1Indicators and Reagents (Reagents)IBA
04/2016
1ImmunosorbentsIBA
02/2016
1May-Grunwald GiemsaIBA
02/2016
1EnzymesIBA
02/2016
1Coloring Agents (Dyes)IBA
02/2016
1p38 Mitogen-Activated Protein KinasesIBA
01/2016
1EndotoxinsIBA
01/2016
1Glycyrrhizic Acid (Glycyrrhizin)IBA
01/2016
1Nitric Oxide Synthase (NO Synthase)IBA
08/2014

Therapy/Procedure

5Therapeutics
05/2022 - 04/2016
3Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2022 - 05/2012
2Wearable Electronic Devices
01/2023 - 12/2022
1Telerehabilitation
01/2023
1Qigong (Qi Gong)
05/2022